Nitroglycerin-induced aortic relaxation mediated by calcium-activated potassium channel is markedly diminished in hypertensive rats

Life Sciences

Volumn 63, Issue 12, 1998, Pages 1047-1055

  Fukami, Yasumasa ^a   Toki, Yukio ^a   Numaguchi, Yasushi ^a   Nakashima, Yoshihito ^a   Mukawa, Hiroaki ^a   Matsui, Hideo ^a   Okumura, Kenji ^a   Ito, Takayuki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cGMP; Charybdotoxin; Hypertension; K(Ca) channel; Methylene blue; Nitroglycerin; Vasorelaxation

Indexed keywords

CALCIUM; CHARYBDOTOXIN; CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; METHYLENE BLUE; POTASSIUM; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; MUSCLE TONE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL ANALYSIS; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0032516535     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00366-X     Document Type: Article

References (27)

1. 1. K. L. AXELSSON, J. E. S. WIKBERG and R. G. G. ANDERSSON, Life Sci. 24 1779-1786 (1979).
2. 2. C. A. GRUETTER, B. K. BARRY, D. B. MCNAMARA, D. Y. GRUETTER, P. J. KADOWITZ and L. J. IGNARRO, J. Cyclic Nucleotide Res. 5 211-224 (1979).
3. 3. T. ITOH, Y. KANMURA, H. KURIYAMA and T. SASAGURI, Brit. J. Pharmacol. 84 393-406 (1985).
4. 4. S. KATSUKI, W. ARNOLD, C. MITTAL and F. MURAD, J. Cyclic Nucleotide Res. 3 23-35 (1977).
5. 5. J. AHLNER, K. L. AXELSSON, P. KARCZEWSKI and R. G. G. ANDERSSON, Pharmacol. Toxicol. 66 277-282 (1990).
6. 6. T. M. LINCOLN and T. L. CORNWEEL, Blood Vessels 28 129-137 (1991).
7. 7. L. J. IGNARRO and P. J. KADOWITZ, Annu. Rev. Pharmacol. Toxicol. 25 171-191 (1985).
8. 8. B. E. ROBERTSON, R. SCHUBERT, J. HESCHELER and M. T. NEESON, Am. J. Physiol. 265 (Cell Physiol. 34) C299-C303 (1993).
9. 9. S. A. KHAN, W. R. MATHEWS and K. D. MEISHERI, J. Pharmacol. Exp. Ther. 267 1327-1335 (1993).
10. 10. K. FUJINO, S. NAKAYA, T. WAKATSUKI, Y. MIYOSHI, Y. NAKAYA, H. MORI, and I. INOUE, J. Pharmacol. Exp. Ther. 256 371-377 (1990).
11. 11. V. M. BOLOTINA, S. NAJIBI, J. J. PALACINO, P. J. PAGANO and R. A. COHEN, Nature 368 850-853 (1994).
12. 12. M. HAMAGUCHI, T. ISHIBASHI and S. IMAI, J. Pharmacol. Exp. Ther. 262 263-270 (1992).
13. 13. M. KONISHI and C. SU, Hypertension 5 881-886 (1983).
14. 14. T. F. LUSCHER and P. M. VANHOUTTE, Hypertension 8 344-348 (1986).
15. 15. N. MIYATA, K. TSUCHIDA, M. TANAKA and S. OTOMO, J. Pharm. Pharmacol. 42 763-766 (1990).
16. 16. Y. OTSUKA, A. DIPIERO, E. HIRT, B. BRENNAMAN and W. LOCKETTE, Am. J. Physiol. 254 (Heart Circ. Physiol. 23) H163-H169 (1988).
17. 17. Y. SHIRASAKl, P. KOLM, G. A. NICKOLS and T. J. F. LEE, J. Pharmacol. Exp. Ther. 245 53-58 (1987).
18. 18. B. TESFAMARIAM and W. HALPERN, Hypertension 11 440-444 (1988).
19. 19. A. L. HARRIS, B. M. LEMP, R. G. BENTLEY, M. H. PERRONE, L. T. HAMEL and P. J. SILVER, J. Pharmacol. Exp. Ther. 249 394-400 (1989).
20. 20. A. PAPAPETROPOULOS, N. MARCZIN, M. D. SNEAD, C. CHENG, A. MILICI and J. D. CATRAVAS, Hypertension 23 476-484 (1994).
21. 21. M. ASANO, K. MASUZAWA-ITO, T. MATSUDA, Y. IMAIZUMI, M. WATANABE and K. ITO, Am. J. Physiol. 265 (Heart Circ. Physiol. 34) H843-H851 (1993).
22. 22. T. J. KOLIAS, S. CHAI and R. C. WEBB, Am. J. Hypertens. 6 528-533 (1993).
23. 23. N. J. RUSCH and A. M. RUNNELLS. Hypertension 23 (part 2):941-945 (1994).
24. 24. T. SHIBATA, K. OGAWA, T. ITO. H. HASHIMOTO. H. NAKAGAWA and T. SATAKE, Jpn. Circ. J. 50 1091-1099 (1986).
25. 25. Y. X. WANG, X. CHENG and C. C. Y. PANG, Brit. J. Pharmacol. 114 194-202 (1995).
26. 26. C. S. ANDERSON, R. MACKINNON, C. SMITH and C. MILLER, J. Gen. Physiol. 91 317-333 (1988).
27. 27. R. MACKINNON and C. MILLER, J. Gen. Physiol. 91 335-349 (1988).